Zoetis
Inc. (NYSE:ZTS) will participate in the Barclays Global
Healthcare Conference on Wednesday, March 16, 2016, in Miami, Fla. Clint
Lewis, Executive Vice President and President, International Operations,
will represent the company and respond to questions from analysts. He is
scheduled to present at 9:00 a.m. EDT.
Investors and other interested parties will be able to access a live
audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations.
A replay of the presentation will also be available on the Zoetis
website at the conclusion of the event.
About Zoetis
Zoetis (zô-EH-tis) is the leading animal
health company, dedicated to supporting its customers and their
businesses. Building on more than 60 years of experience in animal
health, Zoetis discovers, develops, manufactures and markets veterinary
vaccines and medicines, complemented by diagnostic products and genetic
tests and supported by a range of services. Zoetis serves veterinarians,
livestock producers and people who raise and care for farm and companion
animals with sales of its products in more than 100 countries. In 2015,
the company generated annual revenue of $4.8 billion with approximately
9,000 employees. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect the
current views of Zoetis with respect to business plans or prospects,
future operating or financial performance, future guidance, future
operating models, expectations regarding products, future use of cash
and dividend payments, tax rate and tax regimes, changes in the tax
regimes in other jurisdictions, challenges to our efforts to mitigate
the impact of tax decisions, and other future events. These statements
are not guarantees of future performance or actions. Forward-looking
statements are subject to risks and uncertainties. If one or more of
these risks or uncertainties materialize, or if management's underlying
assumptions prove to be incorrect, actual results may differ materially
from those contemplated by a forward-looking statement. Forward-looking
statements speak only as of the date on which they are made. Zoetis
expressly disclaims any obligation to update or revise any
forward-looking statement, whether as a result of new information,
future events or otherwise. A further list and description of risks,
uncertainties and other matters can be found in our Annual Report on
Form 10-K for the fiscal year ended December 31, 2014, including in the
sections thereof captioned “Forward-Looking Information and Factors That
May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly
Reports on Form 10-Q and in our Current Reports on Form 8-K. These
filings and subsequent filings are available online at www.sec.gov,
www.zoetis.com,
or on request from Zoetis.
Zoetis
Media:
Elinore White, 1-973-443-2835 (o)
elinore.y.white@zoetis.com
or
Kristen Seely, 1-973-443-2777 (o)
kristen.seely@zoetis.com
or
Investors:
John O'Connor, 1-973-822-7088 (o)
john.oconnor@zoetis.com
or
Steve Frank, 1-973-822-7141 (o)
steve.frank@zoetis.com